These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37538829)

  • 1. Therapeutic efficacy of
    Ode Y; Pradipta AR; Ahmadi P; Ishiwata A; Nakamura A; Egawa Y; Kusakari Y; Muguruma K; Wang Y; Yin X; Sato N; Haba H; Tanaka K
    Chem Sci; 2023 Aug; 14(30):8054-8060. PubMed ID: 37538829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallic radionuclide-labeled tetrameric 2,6-diisopropylphenyl azides for cancer treatment.
    Ode Y; Pradipta AR; Ishiwata A; Nambu A; Ohnuki K; Mizuma H; Haba H; Tanaka K
    Chem Commun (Camb); 2024 Mar; 60(24):3291-3294. PubMed ID: 38421438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted 1,3-dipolar cycloaddition with acrolein for cancer prodrug activation.
    Pradipta AR; Ahmadi P; Terashima K; Muguruma K; Fujii M; Ichino T; Maeda S; Tanaka K
    Chem Sci; 2021 Apr; 12(15):5438-5449. PubMed ID: 35340932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted cancer cell ablation in mice by an α-particle-emitting astatine-211-labeled antibody against major histocompatibility complex class I chain-related protein A and B.
    Li HK; Hasegawa S; Nakajima NI; Morokoshi Y; Minegishi K; Nagatsu K
    Biochem Biophys Res Commun; 2018 Dec; 506(4):1078-1084. PubMed ID: 30409432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofunctional chemistry and reactivity of biogenic acrolein for cancer diagnosis and therapy.
    Pradipta AR; Tanaka K
    Chem Commun (Camb); 2021 Sep; 57(77):9798-9806. PubMed ID: 34581321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Efficacy of a PSMA-Targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer.
    Hammer S; Hagemann UB; Zitzmann-Kolbe S; Larsen A; Ellingsen C; Geraudie S; Grant D; Indrevoll B; Smeets R; von Ahsen O; Kristian A; Lejeune P; Hennekes H; Karlsson J; Bjerke RM; Ryan OB; Cuthbertson AS; Mumberg D
    Clin Cancer Res; 2020 Apr; 26(8):1985-1996. PubMed ID: 31831560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha radioimmunotherapy using
    Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
    Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a transmission alpha particle dosimetry technique using A549 cells and a Ra-223 source for targeted alpha therapy.
    Al Darwish R; Staudacher AH; Li Y; Brown MP; Bezak E
    Med Phys; 2016 Nov; 43(11):6145. PubMed ID: 27806616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glypican-3-Targeted
    Labadie KP; Hamlin DK; Kenoyer A; Daniel SK; Utria AF; Ludwig AD; Kenerson HL; Li L; Sham JG; Chen DL; Orozco JJ; Yeung RS; Orvig C; Li Y; Wilbur DS; Park JO
    J Nucl Med; 2022 Jul; 63(7):1033-1038. PubMed ID: 34772791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astatine-211-Labeled Gold Nanoparticles for Targeted Alpha-Particle Therapy via Intravenous Injection.
    Huang X; Kaneda-Nakashima K; Kadonaga Y; Kabayama K; Shimoyama A; Ooe K; Kato H; Toyoshima A; Shinohara A; Haba H; Wang Y; Fukase K
    Pharmaceutics; 2022 Dec; 14(12):. PubMed ID: 36559199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior.
    Dekempeneer Y; Bäck T; Aneheim E; Jensen H; Puttemans J; Xavier C; Keyaerts M; Palm S; Albertsson P; Lahoutte T; Caveliers V; Lindegren S; D'Huyvetter M
    Mol Pharm; 2019 Aug; 16(8):3524-3533. PubMed ID: 31268724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular-targeted radioimmunotherapy with the alpha-particle emitter 211At.
    Kennel SJ; Mirzadeh S; Eckelman WC; Waldmann TA; Garmestani K; Yordanov AT; Stabin MG; Brechbiel MW
    Radiat Res; 2002 Jun; 157(6):633-41. PubMed ID: 12005541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pre-clinical characterization of an alpha-emitting sigma-2 receptor targeted radiotherapeutic.
    Makvandi M; Lieberman BP; LeGeyt B; Hou C; Mankoff DA; Mach RH; Pryma DA
    Nucl Med Biol; 2016 Jan; 43(1):35-41. PubMed ID: 26702785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Photodynamic Therapy (PDT) of Lung Cancer with Biotinylated Silicon (IV) Phthalocyanine.
    Dong W; Li K; Wang S; Qiu L; Liu Q; Xie M; Lin J
    Curr Pharm Biotechnol; 2021; 22(3):414-422. PubMed ID: 32386488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetramethylrhodamine is an essential scaffold of azide probe in detecting cellular acrolein.
    Pradipta AR; Fujii M; Tanei T; Morimoto K; Shimazu K; Noguchi S; Tanaka K
    Bioorg Med Chem; 2019 Jun; 27(11):2228-2234. PubMed ID: 31023557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model.
    Jiao H; Zhao X; Liu J; Ma T; Zhang Z; Zhang J; Wang J
    Nucl Med Biol; 2019; 68-69():31-39. PubMed ID: 30578135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice.
    Minnix M; Kujawski M; Poku E; Yazaki PJ; Wong JY; Shively JE
    J Nucl Med; 2022 Dec; 63(12):1859-1864. PubMed ID: 35772959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycyrrhetinic Acid and TAT Peptide Modified Dual-functional Liposomes for Treatment of Hepatocellular Cancer.
    Huang S; Ren D; Wu X; Li M; Yu X; Nie X; Wang Y; Wang Y
    Curr Top Med Chem; 2020; 20(27):2493-2505. PubMed ID: 32703132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy.
    Lee D; Li M; Bednarz B; Schultz MK
    Radiat Res; 2018 Sep; 190(3):236-247. PubMed ID: 29944461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.